Devatis AG - Lenalidomid Devatis 25 mg, Hartkapseln | | 68518 | | 07 | | Lenalidomid Devatis 25 mg | | Hartkapseln | | L04AX04 | | Lenalidomide | | 12.01.2022 | | |
| Composition | lenalidomidum 25.0 mg, lactosum 200.0 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 2.04 mg, magnesii stearas, Kapselhülle: gelatina, titanii dioxidum, Drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, E 172 (nigrum), kalii hydroxidum, pro capsula. | Packungsbestandteile | | Capsules | | | Principe actif | Concentr. |
---|
Lenalidomidum | 25 mg |
| BAG: Principe actif | Concentr. |
---|
Lenalidomidum | 25 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Nigrum) | | | Ammoniae Solutio | 30 | | Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum | | | E 172 | | color. | Gelatina | | Kapselhülle | Kalii Hydroxidum | | | Lacca | | Drucktinte | Lactosum | 200 mg | | Magnesii Stearas | | | Per Centum | | | Pro Capsula | | | Propylenglycol | | | Titanium Dioxide | | |
| |
| |
|